Research Summary
Blood plasma fractionation is the process of separating different components of blood plasma and purifying them into therapeutic products. It is a complex and highly technical process, involving the use of different separation technologies, such as chromatography, centrifugation, filtration, and precipitation. The goal of plasma fractionation is to isolate plasma proteins, such as albumin, immunoglobulins, and clotting factors, which can be used to treat a variety of medical conditions. These proteins are used to produce medications that treat autoimmune diseases, bleeding disorders, and immunodeficiency disorders. Plasma fractionation has revolutionized modern medicine, providing patients with life-saving therapies and medicines.
According to DIResearch's in-depth investigation and research, the global Blood Plasma Fractionation market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Blood Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Biological Engineering, Tiantan Biological Products, Boya Bio-Pharmaceutical, Shuanglin? Bio-pharmacy, Yuanda? Shuyang? Pharmaceutical, Weiguang Biological? Products, Nanyue? Biopharmaceutical, KM Biologics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Blood Plasma Fractionation. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Blood Plasma Fractionation market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Blood Plasma Fractionation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Blood Plasma Fractionation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Blood Plasma Fractionation Include:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Biological Engineering
Tiantan Biological Products
Boya Bio-Pharmaceutical
Shuanglin? Bio-pharmacy
Yuanda? Shuyang? Pharmaceutical
Weiguang Biological? Products
Nanyue? Biopharmaceutical
KM Biologics
Blood Plasma Fractionation Product Segment Include:
Immune Globulin
Coagulation Factor
Albumin
Other
Blood Plasma Fractionation Product Application Include:
Hospital
Retail Pharmacy
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Blood Plasma Fractionation Industry PESTEL Analysis
Chapter 3: Global Blood Plasma Fractionation Industry Porter's Five Forces Analysis
Chapter 4: Global Blood Plasma Fractionation Major Regional Market Size and Forecast Analysis
Chapter 5: Global Blood Plasma Fractionation Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Blood Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Blood Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Blood Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Blood Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Blood Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Blood Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Blood Plasma Fractionation Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Blood Plasma Fractionation Market Overview 1.1 Product Definition and Statistical Scope 1.2 Blood Plasma Fractionation Product by Type 1.2.1 Global Blood Plasma Fractionation Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Immune Globulin 1.2.3 Coagulation Factor 1.2.4 Albumin 1.2.5 Other 1.3 Blood Plasma Fractionation Product by Application 1.3.1 Global Blood Plasma Fractionation Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Hospital 1.3.3 Retail Pharmacy 1.3.4 Other 1.4 Global Blood Plasma Fractionation Market Revenue Analysis (2019-2030) 1.5 Blood Plasma Fractionation Market Development Status and Trends 1.5.1 Blood Plasma Fractionation Industry Development Status Analysis 1.5.2 Blood Plasma Fractionation Industry Development Trends Analysis 2 Blood Plasma Fractionation Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Blood Plasma Fractionation Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Blood Plasma Fractionation Market Analysis by Regions 4.1 Blood Plasma Fractionation Overall Market: 2023 VS 2024 VS 2030 4.2 Global Blood Plasma Fractionation Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Blood Plasma Fractionation Revenue and Market Share by Region (2019-2024) 4.2.2 Global Blood Plasma Fractionation Revenue Forecast by Region (2025-2030) 5 Global Blood Plasma Fractionation Market Size by Type and Application 5.1 Global Blood Plasma Fractionation Market Size by Type 5.2 Global Blood Plasma Fractionation Market Size by Application 6 North America 6.1 North America Blood Plasma Fractionation Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Blood Plasma Fractionation Market Size by Type 6.4 North America Blood Plasma Fractionation Market Size by Application 6.5 North America Blood Plasma Fractionation Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Blood Plasma Fractionation Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Blood Plasma Fractionation Market Size by Type 7.4 Europe Blood Plasma Fractionation Market Size by Application 7.5 Europe Blood Plasma Fractionation Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Blood Plasma Fractionation Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Blood Plasma Fractionation Market Size by Type 8.4 China Blood Plasma Fractionation Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Blood Plasma Fractionation Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Blood Plasma Fractionation Market Size by Type 9.4 APAC (excl. China) Blood Plasma Fractionation Market Size by Application 9.5 APAC (excl. China) Blood Plasma Fractionation Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Blood Plasma Fractionation Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Blood Plasma Fractionation Market Size by Type 10.4 Latin America Blood Plasma Fractionation Market Size by Application 10.5 Latin America Blood Plasma Fractionation Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Blood Plasma Fractionation Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Blood Plasma Fractionation Market Size by Type 11.4 Middle East & Africa Blood Plasma Fractionation Market Size by Application 11.5 Middle East & Africa Blood Plasma Fractionation Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Blood Plasma Fractionation Market Revenue by Key Manufacturers (2020-2024) 12.2 Blood Plasma Fractionation Competitive Landscape Analysis and Market Dynamic 12.2.1 Blood Plasma Fractionation Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Takeda 13.1.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Takeda Blood Plasma Fractionation Product Portfolio 13.1.3 Takeda Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 CSL 13.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 CSL Blood Plasma Fractionation Product Portfolio 13.2.3 CSL Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Grifols 13.3.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Grifols Blood Plasma Fractionation Product Portfolio 13.3.3 Grifols Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Octapharma 13.4.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Octapharma Blood Plasma Fractionation Product Portfolio 13.4.3 Octapharma Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Kedrion 13.5.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Kedrion Blood Plasma Fractionation Product Portfolio 13.5.3 Kedrion Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 LFB Group 13.6.1 LFB Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 LFB Group Blood Plasma Fractionation Product Portfolio 13.6.3 LFB Group Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Biotest 13.7.1 Biotest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Biotest Blood Plasma Fractionation Product Portfolio 13.7.3 Biotest Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 BPL 13.8.1 BPL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 BPL Blood Plasma Fractionation Product Portfolio 13.8.3 BPL Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 RAAS 13.9.1 RAAS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 RAAS Blood Plasma Fractionation Product Portfolio 13.9.3 RAAS Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 CBPO 13.10.1 CBPO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 CBPO Blood Plasma Fractionation Product Portfolio 13.10.3 CBPO Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Hualan Biological Engineering 13.11.1 Hualan Biological Engineering Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Hualan Biological Engineering Blood Plasma Fractionation Product Portfolio 13.11.3 Hualan Biological Engineering Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 Tiantan Biological Products 13.12.1 Tiantan Biological Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Tiantan Biological Products Blood Plasma Fractionation Product Portfolio 13.12.3 Tiantan Biological Products Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Boya Bio-Pharmaceutical 13.13.1 Boya Bio-Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Boya Bio-Pharmaceutical Blood Plasma Fractionation Product Portfolio 13.13.3 Boya Bio-Pharmaceutical Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.14 Shuanglin? Bio-pharmacy 13.14.1 Shuanglin? Bio-pharmacy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 Shuanglin? Bio-pharmacy Blood Plasma Fractionation Product Portfolio 13.14.3 Shuanglin? Bio-pharmacy Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.15 Yuanda? Shuyang? Pharmaceutical 13.15.1 Yuanda? Shuyang? Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.15.2 Yuanda? Shuyang? Pharmaceutical Blood Plasma Fractionation Product Portfolio 13.15.3 Yuanda? Shuyang? Pharmaceutical Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.16 Weiguang Biological? Products 13.16.1 Weiguang Biological? Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.16.2 Weiguang Biological? Products Blood Plasma Fractionation Product Portfolio 13.16.3 Weiguang Biological? Products Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.17 Nanyue? Biopharmaceutical 13.17.1 Nanyue? Biopharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.17.2 Nanyue? Biopharmaceutical Blood Plasma Fractionation Product Portfolio 13.17.3 Nanyue? Biopharmaceutical Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.18 KM Biologics 13.18.1 KM Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.18.2 KM Biologics Blood Plasma Fractionation Product Portfolio 13.18.3 KM Biologics Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Blood Plasma Fractionation Industry Chain Analysis 14.2 Blood Plasma Fractionation Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Blood Plasma Fractionation Typical Downstream Customers 14.4 Blood Plasma Fractionation Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support